Multiple-Dose Pharmacokinetics and Safety of a Novel Broad-Spectrum Cephalosporin (BAL5788) in Healthy Volunteers

Documenti analoghi

• Single-Dose Pharmacokinetics and Safety of a Novel Broad-Spectrum Cephalosporin (BAL5788) in Healthy Volunteers
  di: Schmitt-Hoffmann, Anne, et al.
  Pubblicazione: (2004)
• Single-Ascending-Dose Pharmacokinetics and Safety of the Novel Broad-Spectrum Antifungal Triazole BAL4815 after Intravenous Infusions (50, 100, and 200 Milligrams) and Oral Administrations (100, 200, and 400 Milligrams) of Its Prodrug, BAL8557, in Healthy Volunteers
  di: Schmitt-Hoffmann, Anne, et al.
  Pubblicazione: (2006)
• Efficacy of BAL5788, a Prodrug of Cephalosporin BAL9141, in a Mouse Model of Acute Pneumococcal Pneumonia
  di: Azoulay-Dupuis, E., et al.
  Pubblicazione: (2004)
• Multiple-Dose Pharmacokinetics and Safety of the New Antifungal Triazole BAL4815 after Intravenous Infusion and Oral Administration of Its Prodrug, BAL8557, in Healthy Volunteers
  di: Schmitt-Hoffmann, Anne, et al.
  Pubblicazione: (2006)
• Use of Monte Carlo Simulations To Select Therapeutic Doses and Provisional Breakpoints of BAL9141
  di: Mouton, Johan W., et al.
  Pubblicazione: (2004)